Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
7.00
-0.26 (-3.58%)
At close: Mar 28, 2025, 4:00 PM
6.94
-0.06 (-0.86%)
After-hours: Mar 28, 2025, 7:59 PM EDT
Novavax Employees
Novavax had 952 employees as of December 31, 2024. The number of employees decreased by 591 or -38.30% compared to the previous year.
Employees
952
Change (1Y)
-591
Growth (1Y)
-38.30%
Revenue / Employee
$716,557
Profits / Employee
-$196,953
Market Cap
1.13B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
NVAX News
- 19 days ago - Novavax, Inc. (NVAX) Leerink Partners 2025 Global Healthcare Conference (Transcript) - Seeking Alpha
- 19 days ago - Novavax Announces Changes to Board of Directors - PRNewsWire
- 26 days ago - Novavax, Inc. (NVAX) TD Cowen 45th Annual Health Care Conference (Transcript) - Seeking Alpha
- 4 weeks ago - Novavax Q4 Earnings Review: Long-Term Downsizing Plan Suggests Sell Rating - Seeking Alpha
- 4 weeks ago - Novavax to Participate in Upcoming March Investor Conferences - PRNewsWire
- 4 weeks ago - Novavax, Inc. (NVAX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Novavax Reports Smaller Q4 Loss, Shifts Focus From Commercializing COVID-19 Vaccine To Maximize Value - Benzinga
- 4 weeks ago - Novavax's quarterly loss shrinks as it ramps down spending on COVID vaccines - Reuters